SARS-CoV Peptide Antigen
This peptide from the Spike (S) protein of SARS-CoV is a naturally processed epitope shown to induce specific CTLs. The peptide epitope was validated in binding assay to HLA-A2 of T2 cell line. It also induced specific CD8+ T-cell responses against SARS-CoV. This peptide sequence is also seen within the spike glycoprotein of SARS-CoV2.
Online Inquiry
| CAT# | S29003 |
| Sequence | One Letter Code: VLNDILSRL
Three-Letter Code: H-Val-Leu-Asn-Asp-Ile-Leu-Ser-Arg-Leu-OH |
| Purity | % Peak Area By HPLC ≥ 95% |
| Size | 1 mg NET peptide |
Storage | -20°C |
References | 1. Lv Y, et al. Identification of a novel conserved HLA-A* 0201-restricted epitope from the spike protein of SARS-CoV. BMC immunology. 2009 Dec 1;10(1):61.2. Grifoni A et al. A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2. Cell host & microbe. 2020 Mar 16.3. Ahmed SF et al. Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses. 2020 Mar;12(3):254. |
Write a review
Ask a question
My Review for SARS-CoV Peptide Antigen
Required fields are marked with *
×
Ask a Question for SARS-CoV Peptide Antigen
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
